These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23832258)

  • 1. Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma.
    Çatlı T; Bayazıt Y; Yılmaz A; Menevşe A; Gökdoğan O; Göksu N; Özbilen S
    Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1471-5. PubMed ID: 23832258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of NLRP3 inflammasome in human middle ear cholesteatoma and chronic otitis media.
    Kariya S; Okano M; Zhao P; Kataoka Y; Yoshinobu J; Maeda Y; Ishihara H; Higaki T; Nishizaki K
    Acta Otolaryngol; 2016; 136(2):136-40. PubMed ID: 26457439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of COX-2, ALOX12 and iNOS genes in nasal polyposis].
    Ergin V; Yılmaz A; Celenk F; Uslu S; Ileri F; Menevşe A
    Kulak Burun Bogaz Ihtis Derg; 2012; 22(5):254-8. PubMed ID: 22991985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-2, 12-lipoxygenase, and inducible nitric oxide synthase in head and neck squamous cell carcinoma.
    Celenk F; Bayramoglu I; Yilmaz A; Menevse A; Bayazit Y
    J Craniofac Surg; 2013 Jul; 24(4):1114-7. PubMed ID: 23851751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of C-type lectin receptor mRNA in otitis media with effusion and chronic otitis media with and without cholesteatoma.
    Doo JG; Kim YI; Shim HS; Kim DJ; Park JW; Dong SH; Kim SH; Yeo SG
    Auris Nasus Larynx; 2019 Oct; 46(5):672-680. PubMed ID: 30609964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of C-type lectin receptor mRNA in chronic otitis media with cholesteatoma.
    Kim SH; Han SH; Byun JY; Park MS; Kim YI; Yeo SG
    Acta Otolaryngol; 2017 Jun; 137(6):581-587. PubMed ID: 28440726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Endoplasmic Reticulum Stress Messenger Ribonucleic Acid Expression Between Chronic Otitis Media With and Without Cholesteatoma.
    Kang DW; Kim YJ; Kim SS; Kim YI; Doo JG; Kim SH; Yeo SG
    J Int Adv Otol; 2023 Jul; 19(4):271-276. PubMed ID: 37528590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of cyclooxygenase-2, 12-lipoxygenase, inducible nitric oxide synthase-2 and surfactant protein D in lungs of patients with pulmonary injury caused by sulfur mustard.
    Tahmasbpour E; Ghanei M; Khor A; Panahi Y
    Drug Chem Toxicol; 2019 May; 42(3):257-263. PubMed ID: 29536762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric Oxide Is Locally Produced in the Human Middle Ear and Is Reduced by Acquired Cholesteatoma.
    Westerberg J; Granath A; Drakskog C; Tideholm E; Kumlien Georén S; Weitzberg E; Cardell LO
    Otol Neurotol; 2022 Feb; 43(2):e198-e204. PubMed ID: 34699401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of BMP-2, BMP-4 and BMP-6 on bone destruction of cholesteatoma presence.
    Oger M; Alpay HC; Orhan I; Onalan EE; Yanilmaz M; Sapmaz E
    Am J Otolaryngol; 2013; 34(6):652-7. PubMed ID: 23927997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of long non-coding RNA HOTAIR expression in middle ear cholesteatoma].
    Li Q; Wang HQ; Chen YQ; Xiong S; Zeng L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):250-253. PubMed ID: 29871236
    [No Abstract]   [Full Text] [Related]  

  • 12. Perimatrix of middle ear cholesteatoma: A granulation tissue with a specific transcriptomic signature.
    Jovanovic I; Zivkovic M; Djuric T; Stojkovic L; Jesic S; Stankovic A
    Laryngoscope; 2020 Apr; 130(4):E220-E227. PubMed ID: 31132150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of secretory leukocyte protease inhibitor in middle ear cholesteatoma.
    Lee JK; Chae SW; Cho JG; Lee HM; Hwang SJ; Jung HH
    Eur Arch Otorhinolaryngol; 2006 Dec; 263(12):1077-81. PubMed ID: 16868773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of Dec-205, Bcl-10, Tim-3, and Trem-1 mRNA in chronic otitis media with cholesteatoma.
    Kim MG; Park DC; Oh IH; Kim YI; Choi SA; Jung SY; Kang HM; Yeo SG
    Acta Otolaryngol; 2014 May; 134(5):475-80. PubMed ID: 24702227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of pattern recognition receptors in cholesteatoma.
    Lee HY; Park MS; Byun JY; Kim YI; Yeo SG
    Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):245-53. PubMed ID: 23440434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma.
    Yetiser S; Satar B; Aydin N
    Otol Neurotol; 2002 Sep; 23(5):647-52. PubMed ID: 12218613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and significance of HIF-1alpha and iNOS in human middle ear cholesteatoma epithelium].
    Zhang E; Gong S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 May; 21(10):463-5. PubMed ID: 17650819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential gene expression in cholesteatoma by DNA chip analysis.
    Macias JD; Gerkin RD; Locke D; Macias MP
    Laryngoscope; 2013 Oct; 123 Suppl S5():S1-21. PubMed ID: 23670528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Carcinoembryonic antigen in chronic otitis media with cholesteatoma].
    Sanković-Babić S; Sofronić-Milosavljević Lj
    Srp Arh Celok Lek; 2000; 128(3-4):80-3. PubMed ID: 10932614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesteatoma gene expression of matrix metalloproteinases and their inhibitors by RT-PCR.
    Rezende CE; Souto RP; Rapoport PB; Campos Ld; Generato MB
    Braz J Otorhinolaryngol; 2012 Jun; 78(3):116-21. PubMed ID: 22714856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.